Literature DB >> 16820172

Immunoreactivities of p62, an ubiqutin-binding protein, in the spinal anterior horn cells of patients with amyotrophic lateral sclerosis.

Yuji Mizuno1, Masakuni Amari, Masamitsu Takatama, Hitoshi Aizawa, Ban Mihara, Koichi Okamoto.   

Abstract

An ubiquitin-binding protein, p62, is one of the components of the ubiquitin-containing inclusions in several human neurodegenerative diseases. Amyotrophic lateral sclerosis (ALS) is characterized by the presence of skein-like inclusions, Lewy body-like inclusions, and basophilic inclusions in the remaining anterior horn cells, in which these inclusions contain ubiquitin, while the other characteristic inclusions of Bunina type are ubiquitin-negative. We examined the spinal cord from 28 ALS cases including two ALS with dementia and two ALS with basophilic inclusions, using antibody to p62. The results demonstrated that p62 localized in skein-like inclusions, Lewy body-like inclusions and basophilic inclusions. The number of p62-positive inclusions observed in the remaining anterior horn cells of each section was variable among the ALS cases. In contrast, Bunina bodies, that do not contain ubiquitin, were negative for p62. As far as we examined, the 11 non-ALS cases did not show any p62 immunoreactivities in the anterior horn cells. Our results suggested that p62 plays important roles in forming the inclusions and may be associated with the protection of the neurons from degenerative processes involving ubiquitin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16820172     DOI: 10.1016/j.jns.2006.05.060

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  52 in total

Review 1.  Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.

Authors:  Shahram Saberi; Jennifer E Stauffer; Derek J Schulte; John Ravits
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

2.  RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Authors:  Nadine Bakkar; Arianna Kousari; Tina Kovalik; Yang Li; Robert Bowser
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

3.  ALS-FTLD-linked mutations of SQSTM1/p62 disrupt selective autophagy and NFE2L2/NRF2 anti-oxidative stress pathway.

Authors:  Zhiqiang Deng; Junghyun Lim; Qian Wang; Kerry Purtell; Shuai Wu; Gloria M Palomo; Haiyan Tan; Giovanni Manfredi; Yanxiang Zhao; Junmin Peng; Bo Hu; Shi Chen; Zhenyu Yue
Journal:  Autophagy       Date:  2019-07-30       Impact factor: 16.016

4.  Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons.

Authors:  Disi An; Ryosuke Fujiki; Dylan E Iannitelli; John W Smerdon; Shuvadeep Maity; Matthew F Rose; Alon Gelber; Elizabeth K Wanaselja; Ilona Yagudayeva; Joun Y Lee; Christine Vogel; Hynek Wichterle; Elizabeth C Engle; Esteban Orlando Mazzoni
Journal:  Elife       Date:  2019-06-03       Impact factor: 8.140

5.  Interaction of SQSTM1 with the motor protein dynein--SQSTM1 is required for normal dynein function and trafficking.

Authors:  Luis Calderilla-Barbosa; M Lamar Seibenhener; Yifeng Du; Maria-Theresa Diaz-Meco; Jorge Moscat; Jin Yan; Marie W Wooten; Michael C Wooten
Journal:  J Cell Sci       Date:  2014-07-11       Impact factor: 5.285

Review 6.  Axonal autophagy: Mini-review for autophagy in the CNS.

Authors:  Andrea K H Stavoe; Erika L F Holzbaur
Journal:  Neurosci Lett       Date:  2018-03-13       Impact factor: 3.046

Review 7.  P62/SQSTM1 at the interface of aging, autophagy, and disease.

Authors:  Alessandro Bitto; Chad A Lerner; Timothy Nacarelli; Elizabeth Crowe; Claudio Torres; Christian Sell
Journal:  Age (Dordr)       Date:  2014-02-21

8.  Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS.

Authors:  Noam D Rudnick; Christopher J Griffey; Paolo Guarnieri; Valeria Gerbino; Xueyong Wang; Jason A Piersaint; Juan Carlos Tapia; Mark M Rich; Tom Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-13       Impact factor: 11.205

Review 9.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

10.  Sequestosome 1/p62 links familial ALS mutant SOD1 to LC3 via an ubiquitin-independent mechanism.

Authors:  Jozsef Gal; Anna-Lena Ström; David M Kwinter; Renée Kilty; Jiayu Zhang; Ping Shi; Weisi Fu; Marie W Wooten; Haining Zhu
Journal:  J Neurochem       Date:  2009-09-18       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.